Skip to main content
. Author manuscript; available in PMC: 2016 Aug 9.
Published in final edited form as: Prostate. 2012 Mar 27;72(15):1638–1647. doi: 10.1002/pros.22517

Figure 2. Expression of Shh pathway components in bone marrow metastatic (A,C,E,G) and primary (B,D,F,H) prostate cancer.

Figure 2

Expression of Shh is high in both metastatic (A) and primary (B) prostate cancer. Ptch expression is higher in bone marrow metastasis (C) compared to primary prostate cancer (D). High expression of Gli2 and Gli1 is noted in metastatic and primary prostate cancer (E–H) (original magnification ×200).